Inhaled Interferon α2b for the Treatment of Coronavirus Disease 19 (COVID-19)
Clinical trial NCT04988217 · COMPLETED
Trial details
- NCT number
- NCT04988217
- Sponsor
- Pontificia Universidad Catolica de Chile
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-15
- Primary completion
- 2022-04-15
- Enrollment
- 173
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.